文献速递头颈外科

头颈癌患者12个月决策后悔的社会人口学与临床决定因素

Sociodemographic and Clinical Determinants of 12-Month Decision Regret for Head and Neck Cancer Patients.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-01-31

该回顾性观察性队列研究纳入2018至2023年某学术三级医疗中心225例新诊断头颈癌患者,分析治疗12个月后决策后悔的相关因素。结果显示,60%患者存在轻度决策后悔,28%报告中度至重度后悔;多因素分析显示含放疗的多模式治疗、较低的社会支持及生活质量下降是决策后悔的独立预测因素。

要点

  • 225例头颈癌患者中,60%存在轻度决策后悔,28%报告中度至重度后悔。
  • 含放疗的多模式治疗与决策后悔增加独立相关(aOR 3.67,95%CI 1.25-10.78,P=.018)。
  • 较低的社会支持(aOR 1.03,95%CI 1.00-1.05,P=.039)与生活质量下降(aOR 1.03,95%CI 1.00-1.06,P=.024)为独立预测因素。

核心结论

  • 涉及放疗的治疗、较低的社会支持及生活质量下降与头颈癌患者治疗12个月后的决策后悔相关。
  • 作者认为,旨在增强社会支持、处理治疗相关后遗症及加强共享决策的干预措施可能有助于预防后悔。
  • 需要进一步研究以阐明驱动头颈癌患者亚组后悔的因素,并评估所提出的缓解干预措施的效果。

研究设计与样本

  • 回顾性观察性队列研究,纳入某学术三级医疗中心2018至2023年新诊断头颈癌患者。
  • 分析患者登记库中初诊时及治疗后12个月的生活质量、决策后悔、社会支持及焦虑数据。
  • 仅纳入在12个月时完成决策后悔问卷的患者,共225例参与者。

主要发现

  • 225例参与者中,60%经历轻度决策后悔,28%报告中度至重度后悔。
  • 更强烈的后悔与晚期疾病表现、游离皮瓣重建手术、放化疗及疾病复发相关。
  • 后悔更严重的患者基线及12个月时生活质量较低,12个月时焦虑较高,12个月时社会支持较低。
  • 多因素分析显示,含放疗的多模式治疗(aOR 3.67,95%CI 1.25-10.78,P=.018)、较低的12个月社会支持(aOR 1.03,95%CI 1.00-1.05,P=.039)及生活质量下降(aOR 1.03,95%CI 1.00-1.06,P=.024)是决策后悔增加的独立预测因素。

临床怎么用

  • 作者认为,旨在增强社会支持、处理治疗相关后遗症及加强共享决策的干预措施可能有助于预防后悔。

局限性

  • 需要进一步研究以阐明驱动头颈癌患者亚组后悔的因素,并评估所提出的缓解干预措施的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to identify factors associated with increased decision regret (DR) 12 months following treatment among head and neck cancer (HNC) patients. STUDY DESIGN: A retrospective observational cohort study. SETTING: Patients with newly diagnosed HNC at an academic tertiary care center from 2018 to 2023. METHODS: Data from a patient registry assessing quality of life (QOL), DR, social support, and anxiety at initial diagnosis and 12 months post-treatment were analyzed. Only patients who completed the decision regret questionnaire at 12 months were included. RESULTS: Among 225 participants, 60% experienced mild DR and 28% reported moderate to severe regret. Stronger regret was associated with advanced disease presentation, free flap reconstructive surgery, chemoradiation, and disease recurrence. Patients with more severe regret had lower QOL at baseline and 12 months, higher anxiety at 12 months, and lower social support at 12 months. Multivariable analysis identified multimodal treatment including radiation (adjusted odds ratio [aOR] 3.67, 95% confidence interval [CI] [1.25-10.78], P = .018), lower 12-month social support (aOR 1.03, 95% CI [1.00-1.05], P = .039), and decreases in QOL (aOR 1.03, 95% CI [1.00-1.06], P = .024) as independent predictors of increased DR. CONCLUSION: Treatment involving radiation, lower concurrent social support, and diminished QOL are associated with DR 12 months after treatment. This highlights the potential of interventions aimed at enhancing social support, addressing treatment-related sequelae, and strengthening shared decision-making to prevent regret. Further studies are needed to elucidate factors driving regret in HNC patient subgroups and assess the efficacy of proposed mitigative interventions.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Wang NC, Ramesh UR, Feucht M, et al. Sociodemographic and Clinical Determinants of 12-Month Decision Regret for Head and Neck Cancer Patients. Otolaryngol Head Neck Surg. 2025. PMID: 39887737. doi:10.1002/ohn.1151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。